Gene-therapy in inherited channelopathies like short-QT syndrome: a robust direction towards precision medicine
This editorial refers to ‘AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome’, by S. Nimani et al., https://doi.org/10.1093/eurheartj/ehaf660.Short-QT Syndrome (SQTS) is an inherited channelopathy first described two decades ago. This di...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Article (Journal) Editorial |
| Lingua: | inglese |
| Pubblicazione: |
7 January 2026
|
| In: |
European heart journal
Year: 2026, Volume: 47, Fascicolo: 2, Pages: 214-216 |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/ehaf831 |
| Accesso online: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1093/eurheartj/ehaf831
|
| Note sull'autore: | Nazha Hamdani, Ibrahim Akin, and Ibrahim El-Battrawy |
| Riassunto: | This editorial refers to ‘AAV9-mediated KCNH2 suppression-replacement gene therapy in a transgenic rabbit model of type 1 short QT syndrome’, by S. Nimani et al., https://doi.org/10.1093/eurheartj/ehaf660.Short-QT Syndrome (SQTS) is an inherited channelopathy first described two decades ago. This disorder is associated with sudden cardiac death, atrial fibrillation, and bradycardia occurring in childhood |
|---|---|
| Descrizione del documento: | Gesehen am 12.01.2026 |
| Descrizione fisica: | Online Resource |
| ISSN: | 1522-9645 |
| DOI: | 10.1093/eurheartj/ehaf831 |